Sign in

CIK 0001711279 · Large accelerated filer

Krystal Biotech, Inc.

Sign in to watch
Ticker
KRYS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
821080209
Phone
(412) 586-5830
Business address
2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
  1. 8-K Event Results of operations · Regulation FD disclosure
  2. 8-K Event Regulation FD disclosure
  3. 8-K Event Executive or director change
  4. 4 Planned sale President, R&D sold 50,000 shares at an average $220.15 ($11,007,333)
  5. 4 Planned sale President and CEO sold 50,000 shares at an average $220.15 ($11,007,447)
  6. 144 Insider Sale of Securities
  7. 144 Insider Sale of Securities
  8. 8-K Event Results of operations
  9. 10-Q Report Quarterly Report
  10. 8-K Event Other events
  11. 8-K Event Results of operations
  12. 10-Q Report Quarterly Report
  13. 8-K Event Regulation FD disclosure
  14. 8-K Event Regulation FD disclosure
  15. 4 Planned sale President, R&D sold 35,873 shares at an average $150.39 ($5,395,001)
  16. 4 Planned sale President and CEO sold 35,873 shares at an average $150.39 ($5,395,001)
  17. 4 Planned sale President, R&D sold 14,127 shares at an average $150.27 ($2,122,835)
  18. 4 Planned sale President and CEO sold 14,127 shares at an average $150.27 ($2,122,835)
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 4 of 26 · 513 filings